Both in Pharmaceuticals
Nuvectis Pharma vs Zevra Therapeutics
Over the past year NVCT returned +246.8% and ZVRA returned +18.9%; their daily moves had a correlation of 0.14.
NVCT +246.8% ZVRA +18.9%Growth of $1, one year, split-adjusted
| Metric | NVCT | ZVRA |
|---|---|---|
| Price | $20.53 | $11.34 |
| Market cap | $670.2M | $673.4M |
| Today | −1.35% | +0.35% |
| 1 month | −13.5% | −1.9% |
| 6 months | +174.1% | +29.2% |
| Year to date | +171.9% | +26.6% |
| 1 year | +237.7% | +16.1% |
| Revenue growth (YoY) | — | +53.3% |
| Gross margin | — | 96.2% |
| Net margin | — | 21.2% |
| P/E (TTM) | — | 11.6× |
| Price / sales | — | 4.9× |
| Net cash | $22.2M | $221.6M |
| Dividend yield | — | — |
| Volatility (60d) | 68.0% | 72.1% |
| Short % of float | 10.7% | 10.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).